'Show me the data': FDA commissioner reacts to question about Covid vaccine for young Americans
Sanatate
Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet those prospects were in question when the FDA missed its April 1 target to approve the shot. FDA Commissioner Dr. Marty Makary joins Morning Joe to discuss.
din zilele anterioare